Home    Resource Store    Past Issues    Buyers' Guide    Career Center    Subscriptions    Advertising    E-Newsletter    Contact

March/April 2014 March/April 2014

View Issue  |

Subscribe Now  |


12th International Exhibition on Textile Industry (Indo Intertex 2014)
04/23/2014 - 04/26/2014

Smart Fabrics & Wearable Technology 2014
04/23/2014 - 04/25/2014

04/24/2014 - 04/26/2014

- more events -

- submit your event -

Printer Friendly
Full Site
Nonwovens / Technical Textiles

Kraig Biocraft Laboratories Announces Plans To Launch Initial Commercial Production Of Monster Silk(TM)

LANSING, Mich. — May 7, 2013 — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the "Company"), the leading developer of advanced spider silk based fibers, today announced plans to launch its initial commercial production of Monster Silk(TM). The announcement of the Company's decision to launch commercial production follows the early successes of its of Monster Silk(TM) pilot production program.

"We have received strong indications of interest from potential customers and potential commercialization partners," said, CEO and founder, Kim Thompson. "Many of these companies have been very patient with the fact that our laboratory production has been limited and cannot satisfy their demand for quantities of material sufficient to run test weaves and end product testing.

"Moving from our pilot production program to commercial production is a very big jump, but it is also a natural progression," continued Thompson. "We have been laying the groundwork for this expansion over the last twelve months. We are confident in the decision and we are hopeful that we can accomplish the launch during the third and fourth quarters. Our plan is to begin commercial production to meet customer needs, secure future orders and capture market share in the technical textiles market."

Kraig's pilot production program will continue to run, in order to supply continuing data and help grow the Company's production capacity.

Posted on May 7, 2013

Source: Kraig Biocraft Laboratories Inc.